Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 職業醫學與工業衛生研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34797
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor王榮德(Jung-Der Wang)
dc.contributor.authorWeii-Lun Tsengen
dc.contributor.author曾韋綸zh_TW
dc.date.accessioned2021-06-13T06:34:48Z-
dc.date.available2006-02-09
dc.date.copyright2006-02-09
dc.date.issued2006
dc.date.submitted2006-01-18
dc.identifier.citation1、中醫藥委員會,九十二年十一月四號公告,中醫藥委員會全球資訊網http://www.ccmp.gov.tw/index-c/1.htm (2003/11/27)
2、Kessler DA. Cancer and herbs. New Engl J Med 2000;342:1742-3.
3、FDA(U.S),Dietary Supplements, Center for Food Safety & Applied Nutrition website http://vm.cfsan.fda.gov/~dms/ds-bot.html (2003/11/27)
4、Vanherweghem JL,Depierreux M,Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341:387-91.
5、Cosyns JP,Jadoul M,Squifflet JP, et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy ? Kidney Int 1994; 45:1680-8.
6、Reginster F,Jadoul M, van Ypersele de Strihou C. Chinese herbs nephropathy presentation, natural history, and fate after transplantation. Nephrol Dial Transplant 1997; 12:81-6.
7、Vanherweghem JL,Abramowicz D, Tielemans C, Depierreux M.Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study on Chinese herbs nephropathy. Am J Kidney Dis 1996; 27 : 209-15.
8、Lebeau C, Arlt VM, Schmeiser HH, et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cell. Kidney Int 2001; 60:1332-42.
9、Morrissey JJ, Ishidoya S, McCracken R, et al. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21(WAF21) in experimental renal fibrosis. Kidney Int 1996; 49 (54 suppl.): 83S-7S.
10、IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some traditional Herbal Medicines, some mycotoxins, naphthalene and styrene. IARC monographs on the evaluation of carcinogenic risks, Vol. 82. Lyon : International Agency for Research on Cancer. 2002. p.69.
11、Nortier JL, Muniz Martinez MC, Schmeiser HH et al, Urothelial carcinoma associated with the use of a Chinese herb. New Engl J Med 2000; 342:1686-1692.
12、Lord GM, Tagore R, Cook T, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481-2.
13、Yang CS, Lin CH, Chang SH, Hsu HC, Rapidly progressice interstitial renal fibrosis associated Chinese herbal drug. Am J Kidney Dis 2000; 35: 313-8.
14、Chen HY, Ma B-Y, Grant A, et al. Time to abandon the term ‘Chinese herbs nephropathy’ Kidney Int 2001; 60: 2039-40.
15、Solez K, Daugirdas J, Gregory MC. Et al. Is ‘Chinese herbs nephropathy’ a prejudicial term [letter]. Kidney Int 2001; 38: 1141-2.
16、Cosyns JP. When is‘aristolochic acid nephropathy’ more accurate than ‘Chinese herbs nephropathy’? Kidney int 2002; 61:1178-81.
17、中央健康保險局,統計資料,中央健康保險局全球資訊網http://www.nhi.gov.tw/01intro/intro_3.htm (2003/11/27)
18、Yang CH, Lin CH, Chang SH, Hsu HC. Rapidly progressove initerstitial renal fibrosiss associated Chinese herbal drug. Am J Kidney Dis 2000;35:313-8
19、吳松寒:木通所致急性腎功能衰竭2例報告。江蘇中醫 1964;10:12-14。
20、劉金生、李金田:中藥中毒2例報告。江西中醫藥 1984;5,57-58。
21、劉金湖、曾漢基:大量煎服關木通致急性腎功能衰竭死亡一例。中國中醫藥雜誌 1994;19: 692。
22、黎磊石:由木通腎毒性研究帶來的思考.腎臟病與透析腎移植雜誌,1999;8:1-2。
23、諶貽璞,陳文:馬兜鈴酸腎病存在四種臨床病理類型。中華腎臟病雜 2000;16:406-407。
24、Brain S. What is pharmacoepidemiology. In Brain S. ed., Pharmacoepidemiology. Chichester: John Wiley& Sons Ltd 2000; 3-15.
25、國家衛生研究院,承保抽樣歸人檔,全民健康保險研究資料庫全球資訊網http://www.nhri.org.tw/nhird/date_cohort.htm (2004/12/3)
26、國家衛生研究院,各檔間串檔變項說明,全民健康保險研究資料庫全球資訊網http://www.nhri.org.tw/nhird/file_talk/connect2.jpg(2004/12/3)
27、工研院生醫中心,台灣中草藥市場,醫藥工業資訊網 http://biomed.itri.org.tw/market/cmedicine/cmedicine06.asp(2005/04/18)
28、中醫藥委員會,基準方劑,中醫藥資訊網全球資訊網http://www.ccmp.gov.tw/index-c/1.htm(2004/12/3)
29、中央健康保險局,健保用藥品項,中央健康保險局全球資訊網http://www.nhi.gov.tw/02hospital/hospital_6_01.htm(2004/12/3)
30、李承華、周穎政、陳龍生、張鴻仁:全民健保中醫門診利用率及其影響因素。台灣衛誌 2004;23:100-107。
31、徐雅慧、羅吉方、張憲昌、林哲輝:市售細辛藥材之鑑別。藥物食品檢驗局調查研究年報 2003;21:153-167。
32、Jong TT. Lee MR. Hsiao SS. Hsai JL. Wu TS. Chiang ST. Cai SQ. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J Pharm Biomed Anal 2003; 33(4): 831-7.
33、黃淑貞、余萬能:社區藥局與診所取藥病人遵醫囑行為研究。公共衛生 2001;27:245-60。
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34797-
dc.description.abstract目標:本研究的目的在描述全民健保中可能含馬兜鈴科植物方劑使用概況,與連續服用三個月以上發生中藥腎病變的處方方式作比較。方法:使用國家衛生研究院20萬人健保抽樣歸人檔,對回溯的資料庫進行含細辛、防己、木通、木香、馬兜鈴及天仙藤中藥處方的全民使用率及性別、累積天數、處方年齡分層分析。結果:本研究發現在1997-2001年間,扣除資料不全後中醫門診總處方次數5098390次共103630人。六類方劑總處方次數為361333次共64216人;全民使用率為64.2*10-3年-1。女性較多。六類中最常用的為細辛類。六類方劑的平均處方年齡為37.9±19.3,35-44歲的處方次數為76964次。除細辛類為15歲以下,其餘各類均以35-44歲最多。每次處方開立天數均以一周內為多,8天以上者,六類方加起來共5999次。第一次服用這六類方劑平均年齡為34.9±18.8歲;除細辛類為十五歲以下天仙藤類為25-34歲;其餘均以35-44歲第一次使用最多。六類方劑累積服用天數為32.9±56.1,1-30天者有46335人,而各類方劑累積服用天數以1-30天為最常見,六類處方總累積天數超過三個月有5089人。結論:國內對馬兜鈴科的細辛類藥物仍可以使用,本研究發現這類藥物的使用十分廣泛而且使用年齡層較低;雖然累積天數並不像國外一樣長期;但最常使用的為15歲以下,危險劑量是否較成人為低及長期累積是否有不良影響;值得加以進一步研究。zh_TW
dc.description.abstractObject:This study was conducted to determine the current prescription patterns of Chinese Herb Medicine May Containing Plant Species of the Genus Aristolochia in National Health Insurance in Taiwan between 1997-2001. and explore the different of prescription patterns between Taiwan’s regular using and Belgian’s Chinese herbs nephropathy cases. Method:The database containing 200,000 people randomly sampled from the National Health Insurance (NHI) system during 1997-2001 was used. The retrospective cohort was stratified for age, gender, cumulative prescribing days of mixtures containing Si-sin、Fang-ji、Mu-tong、Mu-siang、tian-sian-teng and Ma-dou-ling. Result:103630 people used Chinese medicine service and had 5098390 prescriptions between 1997-2001. There were 64216 people taking 361333 prescriptions containing these six kinds of drug, with a mean prescribing age of 37.9±19.3 and 76964 prescriptions between 35-44 years old. Using incidence rate of hole people is 64.2*10-3Year-1.Female gender is more than male. The mixture contain Si-Sin is the highest. All other kinds of mixtures had the most popular age range between 35-44 expecting Si-sin is under the 15 years old. 5999 prescriptions of six kinds of mixture had individual prescribing day more than eight days. The mean age of first time taking prescription of seven mixtures are 34.9±18.8 years old; all had the most popular age range between 35-44 expecting Si-sin is under the 15 and tian-sian-teng is between 25-34 years old. The cumulative prescribing day of all seven kinds of mixture is 32.9±56.1 days; 46355 people were less than 30 days. 5089 people had cumulative prescribing day more than 3 months. Conclusion:In Taiwan, the Chinese Herb Containing Plant Species of the Genus Aristolochia is no more used expect Si-sin. Our study find the using of mixture contain Si-sin is popular. Although the cumulative prescribing day is not as long as Belgian’s cases, Sin-Sin is frequently used in children under 15 years old. They may have lower danger dose than adult and has much long life time for cumulative dose. It is very crucial to further clarify the effect of Si-Sin on kidney function and urinary cancer in the future.en
dc.description.provenanceMade available in DSpace on 2021-06-13T06:34:48Z (GMT). No. of bitstreams: 1
ntu-95-R91841009-1.pdf: 281618 bytes, checksum: d93c1fd39462ab522cff7db6d018da61 (MD5)
Previous issue date: 2006
en
dc.description.tableofcontents摘要……………………………………… 1
ABSTRACT………………………………… 2
目錄……………………………………… 3
表列……………………………………… 4
圖列……………………………………… 5
壹、前言………………………………… 6
貳、文獻探討…………………………… 7
叁、材料與方法………………………… 12
肆、結果………………………………… 19
伍、討論………………………………… 33
陸、結論………………………………… 36
柒、參考文獻………………………… 37
附錄壹、各類方第一診斷碼(ICD9_1)前十名……41
附錄貳、1997-2001馬兜鈴相關各方劑開立概況……43
dc.language.isozh-TW
dc.subject細辛zh_TW
dc.subject馬兜鈴酸zh_TW
dc.subject腎毒性zh_TW
dc.subject中草藥zh_TW
dc.subject全民健保zh_TW
dc.subjectNephrotoxicityen
dc.subjectSi-Sinen
dc.subjectNational Health Insuranceen
dc.subjectChinese herb medicineen
dc.subjectAristolochic aciden
dc.title1997-2001年全民健保馬兜鈴酸相關方劑處方概況zh_TW
dc.titleFrequency of Prescribing Chinese Herb Medicine May Containing Plant Species of the Genus Aristolochia in National Health Insurance in Taiwan Between 1997-2001en
dc.typeThesis
dc.date.schoolyear94-1
dc.description.degree碩士
dc.contributor.oralexamcommittee陳保中(Pau-Chung Chen),林宜信
dc.subject.keyword馬兜鈴酸,腎毒性,中草藥,全民健保,細辛,zh_TW
dc.subject.keywordAristolochic acid,Nephrotoxicity,Chinese herb medicine,National Health Insurance,Si-Sin,en
dc.relation.page52
dc.rights.note有償授權
dc.date.accepted2006-01-18
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept職業醫學與工業衛生研究所zh_TW
顯示於系所單位:職業醫學與工業衛生研究所

文件中的檔案:
檔案 大小格式 
ntu-95-1.pdf
  未授權公開取用
275.02 kBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved